NRXS - NeurAxis, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

NRXS

NEURAXIS, INC.

AMEX

$6.00

▼ DOWN 0.33% (-0.02)

KEY STATISTICS

Market Cap$74.86 M

52w High$9.33

52w Low$2.21

Dividend Yield—

Frequency—

P/E-7.41

Volume40.21K

Shares Out.12.48M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Brian Carrico

COMPENSATION 2026

Salary$345,102

Stock Awards$388,841

Incentive Plan Pay$0

All Other Comp.$0

Total$936,439

ABOUT

SECTOR

Healthcare

WENT PUBLIC

August 9, 2023

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

PRICE TARGET

Target High$8.00

Target Low$8.00

Target Median$8.00

Target Consensus$8.00

UPCOMING EARNINGS

DateNov 17, 2026

DayTuesday

Rev. Est.$2.30M

NOV

TUE

PRICE

$6.00 ▼ DOWN 0.33% (−$0.02)

About NeurAxis, Inc.

https://neuraxis.com ↗

NeurAxis, Inc., founded in 2011 and based in Carmel, Indiana, develops neuromodulation devices like IB-Stim for treating functional abdominal pain in patients aged 11-18, primarily serving hospitals and clinics.

INDUSTRY

Biotechnology

A PRODUCT NEURAXIS, INC. IS KNOWN FOR

IB-Stim

IB-Stim is an FDA-cleared non-invasive neuromodulation device that uses percutaneous electrical nerve field stimulation behind the ear to treat IBS-related abdominal pain and dyspepsia in both children and adults.

COMPETITORS

COMPETITOR

Revenue by Products

Icon	PRODUCT	Q1-2025	Q2-2025	Q3-2025
	Operating Segments	$895.65K	$894.09K ▼	$811.41K ▼

Revenue by Geography

REGION	Q2-2023	Q3-2023	Q4-2023
All Other States	$245.02K	$126.17K ▼	$473.26K ▲
CANADA	$162.7K	$138.07K ▼	—
OHIO	$149.3K	$129.2K ▼	$129.13K ▼
FLORIDA	$52.58K	$37.81K ▼	$96.45K ▲
MACAO	$45.02K	$95.03K ▲	—
ISRAEL	$53.1K	$21.51K ▼	—